These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7427268)

  • 1. Hyperlipidaemia advances and retreats.
    Br Med J; 1980 Aug; 281(6236):340-1. PubMed ID: 7427268
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperlipidemia and coronary disease].
    Krikler DM
    Coeur Med Interne; 1976; 15(1):3-10. PubMed ID: 793762
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 4. Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.
    Schapel GJ; Edwards KD; Neale FC
    Prog Biochem Pharmacol; 1974; 9():82-98. PubMed ID: 4438384
    [No Abstract]   [Full Text] [Related]  

  • 5. A pathophysiologic approach to managing hyperlipemia.
    Hazzard WR
    Am Fam Physician; 1976 Aug; 14(2):78-87. PubMed ID: 941821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of essential hyperlipidaemia.
    Fredrickson DS; Levy RI
    Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract]   [Full Text] [Related]  

  • 7. The investigation and treatment of hyperlipidaemia in general practice.
    Tierney E
    Practitioner; 1975 Mar; 214(1281):393-6. PubMed ID: 1144258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hyperlipidemia].
    Itakura H
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1750-5. PubMed ID: 1336024
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
    Huth K; Blumenthal J; Schmahl FW
    Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of excess serum lipid.
    N Engl J Med; 1971 May; 284(19):1102-4. PubMed ID: 5553205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug prevention of coronary disease].
    Miettinen TA
    Duodecim; 1972; 88(21):1346-54. PubMed ID: 4570871
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperlipidemia: to treat or not to treat.
    Parsons WB
    Ariz Med; 1975 Apr; 32(4):323-8. PubMed ID: 1119953
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical aspects of hyperlipidaemia.
    Durrington PN; Miller JP
    Br J Hosp Med; 1984 Jul; 32(1):28-34. PubMed ID: 6378296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angina pectoris--II.
    Br Med J; 1971 Mar; 1(5748):545-7. PubMed ID: 5547579
    [No Abstract]   [Full Text] [Related]  

  • 15. The pediatrician's role in genetic hyperlipidemias.
    Schleman MM
    Del Med J; 1981 Sep; 53(9):473-4. PubMed ID: 7338289
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Screening for hyperlipidaemia in childhood.
    Lloyd JK; Fosbrooke AS; West R; Wolff OH
    Br Med J; 1975 Jan; 1(5948):35. PubMed ID: 1120225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of hyperlipidemias].
    Sailer S
    Wien Klin Wochenschr; 1971 Oct; 83(39):691-4. PubMed ID: 5165100
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current studies on antilipemic agents].
    Kanaide H; Nakamura M
    Nihon Rinsho; 1975 Nov; 33(11):3205-10. PubMed ID: 173903
    [No Abstract]   [Full Text] [Related]  

  • 19. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
    Roe DA
    Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atherosclerosis. Its implications, prevention and dietetic and pharmacological treatment].
    Sangiorgi M; Martinelli M
    Minerva Med; 1978 Dec; 69(61):4227-33. PubMed ID: 733078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.